dronedarone has been researched along with Cardiac Diseases in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Delgado-Baeza, E; Delgado-Martos, MJ; Desco, M; Gomez de Diego, JJ; Muñoz-Valverde, D; Quintana-Villamandos, B; Soto-Montenegro, ML | 1 |
Wehling, M | 1 |
3 other study(ies) available for dronedarone and Cardiac Diseases
Article | Year |
---|---|
Dronedarone produces early regression of myocardial remodelling in structural heart disease.
Topics: Amiodarone; Animals; Atrial Fibrillation; Atrial Remodeling; Dronedarone; Heart Diseases; Humans; Hypertension; Hypertrophy, Left Ventricular; Positron Emission Tomography Computed Tomography; Rats; Rats, Inbred SHR | 2017 |
Dronedarone: liver damage and cardiac disorders. Negative harm-benefit balance.
Topics: Amiodarone; Anti-Arrhythmia Agents; Chemical and Drug Induced Liver Injury; Dronedarone; Heart Diseases; Humans; Renal Insufficiency | 2011 |
[Who protects physicians and patients from guidelines?].
Topics: Adenosine; Aged; Amiodarone; Anti-Arrhythmia Agents; Consensus Development Conferences as Topic; Dronedarone; Drug Approval; Early Termination of Clinical Trials; Evidence-Based Medicine; Germany; Guideline Adherence; Heart Diseases; Humans; Malpractice; National Health Programs; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Ticagrelor | 2011 |